OBJECTIVE: To evaluate the efficacy of patient and staff cohorting to control vancomycin-resistant enterococci (VRE) at an Indianapolis community hospital. DESIGN: To interrupt transmission of VRE, a VRE point-prevalence survey of hospital inpatients was conducted, and VRE-infected or -colonized patients were cohorted on a single ward with dedicated nursing staff and patient-care equipment. To assess the impact of the intervention, staff compliance with contact isolation procedures was observed, and the VRE point-prevalence survey was repeated 2 months after the cohort ward was established. RESULTS: Following the establishment of the cohort ward, VRE prevalence among all hospitalized inpatients decreased from 8.1% to 4.7% (25 positive cultures among 310 patients compared to 13 positive cultures among 276 patients, P=.14); VRE prevalence among patients whose VRE status was unknown before cultures were obtained decreased from 5.9% to 0.8% (18 positive cultures among 303 patients compared to 2 positive cultures among 262 patients, P=.002); and observed staff-patient interactions compliant with published isolation recommendations increased (5 [22%] of 23 interactions compared to 36 [88%] of 41 interactions, P<.0001). CONCLUSIONS: Our data suggest that, in hospitals with endemic VRE or continued VRE transmission despite implementation of contact isolation measures, establishing a VRE cohort ward may be a practical and effective method to improve compliance with infection control measures and thereby to control epidemic or endemic VRE transmission.
OBJECTIVE: To evaluate the efficacy of patient and staff cohorting to control vancomycin-resistant enterococci (VRE) at an Indianapolis community hospital. DESIGN: To interrupt transmission of VRE, a VRE point-prevalence survey of hospital inpatients was conducted, and VRE-infected or -colonized patients were cohorted on a single ward with dedicated nursing staff and patient-care equipment. To assess the impact of the intervention, staff compliance with contact isolation procedures was observed, and the VRE point-prevalence survey was repeated 2 months after the cohort ward was established. RESULTS: Following the establishment of the cohort ward, VRE prevalence among all hospitalized inpatients decreased from 8.1% to 4.7% (25 positive cultures among 310 patients compared to 13 positive cultures among 276 patients, P=.14); VRE prevalence among patients whose VRE status was unknown before cultures were obtained decreased from 5.9% to 0.8% (18 positive cultures among 303 patients compared to 2 positive cultures among 262 patients, P=.002); and observed staff-patient interactions compliant with published isolation recommendations increased (5 [22%] of 23 interactions compared to 36 [88%] of 41 interactions, P<.0001). CONCLUSIONS: Our data suggest that, in hospitals with endemic VRE or continued VRE transmission despite implementation of contact isolation measures, establishing a VRE cohort ward may be a practical and effective method to improve compliance with infection control measures and thereby to control epidemic or endemic VRE transmission.
Authors: T Okabe; K Oana; Y Kawakami; M Yamaguchi; Y Takahashi; Y Okimura; T Honda; T Katsuyama Journal: J Clin Microbiol Date: 2000-06 Impact factor: 5.948
Authors: Laura H Rosenberger; Tjasa Hranjec; Amani D Politano; Brian R Swenson; Rosemarie Metzger; Hugo Bonatti; Robert G Sawyer Journal: Surg Infect (Larchmt) Date: 2011-09-21 Impact factor: 2.150
Authors: Suzanne M Paule; William E Trick; Fred C Tenover; Mary Lankford; Susan Cunningham; Valentina Stosor; Ralph L Cordell; Lance R Peterson Journal: J Clin Microbiol Date: 2003-10 Impact factor: 5.948
Authors: R-P Vonberg; I F Chaberny; A Kola; F Mattner; S Borgmann; M Dettenkofer; D Jonas; A-M Fahr; I Klare; G Werner; K Weist; C Wendt; P Gastmeier Journal: Anaesthesist Date: 2007-02 Impact factor: 1.041
Authors: Erica S Shenoy; Hang Lee; Erin E Ryan; Taige Hou; Rochelle P Walensky; Winston Ware; David C Hooper Journal: Med Decis Making Date: 2017-06-29 Impact factor: 2.583
Authors: Laura H Rosenberger; Lin M Riccio; Kristin Turza Campbell; Amani D Politano; Robert G Sawyer Journal: Surg Infect (Larchmt) Date: 2012-04 Impact factor: 2.150
Authors: C W Hendrix; J M Hammond; S M Swoboda; W G Merz; S M Harrington; T M Perl; J D Dick; D M Borschel; P W Halczenko; R K Pelz; L E Rocco; J E Conway; R G Brower; P A Lipsett Journal: Ann Surg Date: 2001-02 Impact factor: 12.969
Authors: Young Kyung Yoon; Hee Sun Sim; Jeong Yeon Kim; Dae Won Park; Jang Wook Sohn; Kyung Ho Roh; Seung Eun Lee; Min Ja Kim Journal: Yonsei Med J Date: 2009-10-21 Impact factor: 2.759